Patients typically describe a significant reduction in food noise the persistent mental focus on eating within the first few weeks of treatment
You can read the full article at Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial In a phase 3 trial conducted in Japan, the efficacy and safety of tirzepatide, a new medication for type 2 diabetes, were compared to dulaglutide
Scenario 1: weekly injection from a multi-dose vial You take the vial from the fridge, draw your dose, and return it within 10 minutes
They can look at your health history, answer your questions, and help you decide if Ozempic is the right option for your weight loss goals
Tirzepatide produced a 33.9% reduction in fat mass alongside a 10.9% reduction in lean mass